SRZN
Surrozen Inc

1,135
Mkt Cap
$115.71M
Volume
74,513.00
52W High
$18.17
52W Low
$5.90
PE Ratio
-0.62
SRZN Fundamentals
Price
$13.73
Prev Close
$13.50
Open
$13.94
50D MA
$12.93
Beta
0.46
Avg. Volume
42,006.17
EPS (Annual)
-$21.67
P/B
-4.92
Rev/Employee
$259,878.05
Loading...
Loading...
News
all
press releases
Insider Buying: Surrozen (NASDAQ:SRZN) Major Shareholder Acquires 315,457 Shares of Stock
Surrozen, Inc. (NASDAQ:SRZN - Get Free Report) major shareholder Group Gp Lp Column III purchased 315,457 shares of the stock in a transaction on Thursday, November 13th. The shares were bought at an...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Lifesci Capital Forecasts Surrozen FY2025 Earnings
Surrozen, Inc. (NASDAQ:SRZN - Free Report) - Lifesci Capital issued their FY2025 earnings per share (EPS) estimates for shares of Surrozen in a report issued on Thursday, November 13th. Lifesci...
MarketBeat·4d ago
News Placeholder
Surrozen (NASDAQ:SRZN) Stock Rating Upgraded by Lifesci Capital
Lifesci Capital upgraded shares of Surrozen to a "strong-buy" rating in a research note on Thursday...
MarketBeat·5d ago
News Placeholder
HC Wainwright Brokers Reduce Earnings Estimates for Surrozen
Surrozen, Inc. (NASDAQ:SRZN - Free Report) - Equities research analysts at HC Wainwright lowered their Q4 2025 earnings estimates for Surrozen in a research report issued to clients and investors on...
MarketBeat·7d ago
News Placeholder
What is HC Wainwright's Estimate for Surrozen Q1 Earnings?
Surrozen, Inc. (NASDAQ:SRZN - Free Report) - Research analysts at HC Wainwright issued their Q1 2026 earnings estimates for Surrozen in a report issued on Monday, November 10th. HC Wainwright analyst...
MarketBeat·8d ago
News Placeholder
Surrozen (NASDAQ:SRZN) Posts Earnings Results, Misses Expectations By $2.44 EPS
Surrozen (NASDAQ:SRZN - Get Free Report) released its quarterly earnings results on Friday. The company reported ($3.61) EPS for the quarter, missing analysts' consensus estimates of ($1.17) by...
MarketBeat·11d ago
News Placeholder
Down -29.72% in 4 Weeks, Here's Why Surrozen (SRZN) Looks Ripe for a Turnaround
Zacks·6mo ago
News Placeholder
Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis
In a preclinical model of pulmonary fibrosis, a Surrozen antibody-based SWAP platform molecule decreased pulmonary inflammation and fibrosis and improved lung function Surrozen Wnt mimetic SWAP...
Globe Newswire·2y ago
News Placeholder
Surrozen announces up to $192.5M private placement of securities priced at-the-market under Nasdaq rules
Surrozen announces up to $192.5M private placement of securities priced at-the-market under Nasdaq rules...
Seeking Alpha - Healthcare·2y ago
News Placeholder
Surrozen announces up to $192.5M private placement
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago

Latest SRZN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.